US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

210.53

-0.5100-0.24%

Pre-market: 211.420.8900+0.42%08:52 EDT

Volume:1.94M

Turnover:410.08M

Market Cap:10.68B

PE:33.35

High:212.62

Open:210.89

Low:209.84

Close:211.04

52wk High:217.12

52wk Low:144.65

Shares:50.75M

Float Shares:50.75M

Volume Ratio:1.36

T/O Rate:3.82%

Dividend:0.34

Dividend Rate:0.16%

EPS(TTM):6.31

EPS(LYR):35.34

ROE:24.54%

ROA:0.10%

PB:1.31

PE(LYR):5.96

Loading ...

Overview Company News Filings

Abeona Therapeutics ‘congratulated’ Ultragenyx on U.S FDA approval of UX111

Patent Expirations and R&D Gaps Create a Looming Biologic Shortfall, Potentially Costing the U.S. Healthcare System $189 Billion

Tissue Repair Shareholders Approve Delisting and Equal Access Buyback

Vertex wins approval for 24/7 underground operations at Reward Gold Mine

Alterity Therapeutics to Spotlight MSA Program at ASX SMIDcaps Conference

Vortex Energy Moves to Acquire Saskatchewan Meadows Project for Future Energy Storage Potential

TuHURA Biosciences Expands Use of Revolving Credit Facility

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Moderna Inc. Stock Climbs 8.5%, Outperforms Peers

Ultragenyx confirms FDA approval of Fayuvi

Sector Update: Healthcare

MT Newswires Live

FDA approves Ultragenyx gene therapy for Sanfilippo syndrome type A

Argenx Expands Kidney Pipeline With New IgA Nephropathy Trial

Amgen Targets First-Line ITP Market With New Phase 3 Romiplostim Trial

Argenx Se : Jefferies Raises Target Price to $1235 from $1215

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and Amgen (AMGN)

Nuvation Bio announces FDA approval of sNDA for Ibtrozi

Tiziana Life Sciences Signs Saudi Collaboration MOU for New Multiple Sclerosis Trial

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Atricure (ATRC) and Stryker (SYK)

Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/IBB/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"iShares Biotechnology ETF","latestPrice":210.53,"timestamp":1790798400000,"preClose":211.04,"halted":0,"volume":1939806,"hourTrading":{"tag":"盘前","latestPrice":211.42,"preClose":210.53,"latestTime":"08:52 EDT","volume":183,"amount":38520.003059999995,"timestamp":1790859176434,"change":0.89,"changeRate":0.004227,"amplitude":0.010126},"delay":0,"changeRate":-0.00241660348749048,"floatShares":50750000,"shares":50750000,"eps":6.311863,"marketStatus":"Pre-Mkt","change":-0.51,"latestTime":"10-01 08:58:21 EDT","open":210.89,"high":212.62,"low":209.84,"amount":410084027.89596003,"amplitude":0.013173,"askPrice":211.42,"askSize":300,"bidPrice":210.53,"bidSize":1,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790861400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":210.53,"sharesOutstanding":49450000,"nav":211.023541,"aum":11226452381.2,"dividendRate":0.001601,"bidAskSpread":0.000363,"preHourTrading":{"tag":"盘前","latestPrice":211.42,"preClose":210.53,"latestTime":"08:52 EDT","volume":183,"amount":38520.003059999995,"timestamp":1790859176434,"change":0.89,"changeRate":0.004227,"amplitude":0.010126},"postHourTrading":{"tag":"盘后","latestPrice":210.53,"preClose":210.53,"latestTime":"19:40 EDT","volume":10410,"amount":2191616.46,"timestamp":1790811644228,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.3570641834940482,"impliedVol":0.2393,"impliedVolPercentile":0.58},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50750000,"roa":"0.10%","roe":"24.54%","lyrEps":35.344796,"volumeRatio":1.3570641834940482,"shares":50750000,"dividePrice":0.3371,"high":212.62,"amplitude":0.013173,"preClose":211.04,"low":209.84,"week52Low":144.65,"pbRate":"1.31","psRate":"257.06","week52High":217.12,"institutionHeld":0,"latestPrice":210.53,"committee":-0.993355,"eps":6.311863,"divideRate":0.001601,"volume":1939806,"delay":0,"ttmEps":6.311863,"open":210.89,"prevYearClose":168.77,"prevWeekClose":209.77,"prevMonthClose":210.53,"prevQuarterClose":210.53,"fiveDayClose":206.6,"twentyDayClose":210.82,"sixtyDayClose":198.23},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"IBB","amount":0.011194,"announcedDate":"2026-09-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-09-18"},{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"},{"executeDate":"2018-06-26","recordDate":"2018-06-27","paymentDate":"2018-07-02","value":0.15606,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668282679","title":"Abeona Therapeutics ‘congratulated’ Ultragenyx on U.S FDA approval of UX111","url":"https://stock-news.laohu8.com/highlight/detail?id=2668282679","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668282679?lang=en_us&edition=fundamental","pubTime":"2026-09-18 19:35","pubTimestamp":1789731320,"startTime":"0","endTime":"0","summary":"Abeona Therapeutics (ABEO) “congratulated” Ultragenyx Pharmaceutical (RARE) on the U.S. Food and Drug Administration, FDA, approval of FAYUVI, also...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abeona-therapeutics-congratulated-ultragenyx-on-u-s-fda-approval-of-ux111-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abeona-therapeutics-congratulated-ultragenyx-on-u-s-fda-approval-of-ux111-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4585","MRNY","PINK","IYH","RARE","XLVX","SYNB","NVIB","RSPH","ABEO","LFSC","MEDI","GDOC","BK4588","BBP","BMED","GNMX","IBB","IDNA","IEIH","PSCH","FRTY","LABU","TECB","TBXU","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131230465","title":"Patent Expirations and R&D Gaps Create a Looming Biologic Shortfall, Potentially Costing the U.S. Healthcare System $189 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1131230465","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131230465?lang=en_us&edition=fundamental","pubTime":"2026-09-18 09:54","pubTimestamp":1789696466,"startTime":"0","endTime":"0","summary":"A recent industry analysis warns that over the next decade, nearly 90% of biologic drugs losing their market exclusivity will lack a corresponding biosimilar in development, creating a significant...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","LU2272731782.SGD","PPH","BK4588","IE00B5TLWC47.USD","159891","LU2473716301.USD","LU2272731600.USD","XPH","BK4585","LU2322448791.USD","LU2322448957.HKD","LU1992135399.USD","LU2272731865.HKD","LU1992135472.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668916898","title":"Tissue Repair Shareholders Approve Delisting and Equal Access Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2668916898","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668916898?lang=en_us&edition=fundamental","pubTime":"2026-09-18 09:07","pubTimestamp":1789693634,"startTime":"0","endTime":"0","summary":"Tissue Repair Ltd ( ($AU:TRP) ) just unveiled an update. Tissue Repair Limited, a Phase 3-stage biotechnology company, is developing second-generat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tissue-repair-shareholders-approve-delisting-and-equal-access-buyback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tissue-repair-shareholders-approve-delisting-and-equal-access-buyback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FHLC","IEIH","AGNG","FWD","XT","BBP","IBB","BK4585","JDOC","RSPH","LNGR","SYNB","BK4588","DARP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668914913","title":"Vertex wins approval for 24/7 underground operations at Reward Gold Mine","url":"https://stock-news.laohu8.com/highlight/detail?id=2668914913","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668914913?lang=en_us&edition=fundamental","pubTime":"2026-09-18 08:18","pubTimestamp":1789690694,"startTime":"0","endTime":"0","summary":"An announcement from Vertex Minerals Ltd. ( ($AU:VTX) ) is now available. Vertex Minerals has secured a varied Environment Protection License from ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-wins-approval-for-24-7-underground-operations-at-reward-gold-mine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-wins-approval-for-24-7-underground-operations-at-reward-gold-mine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1674673691.USD","IDNA","VERX","BBH","PBE","IE00B894F039.SGD","LU0079474960.USD","LU2236285917.USD","LU2362540622.SGD","LU0432979614.USD","LU2324357040.USD","LU1035775433.USD","IE00BZ9MQY76.HKD","SG9999001176.USD","LU0889565916.HKD","SG9999013999.USD","BK4585","LU1778281490.HKD","LU0757428866.USD","BIB","IE00B19Z9Z06.USD","IE00B19Z9P08.USD","SGXZ57979304.SGD","VRTX","LU1430594728.SGD","LU2362541513.USD","IE0009355771.USD","IE0002141913.USD","LU0058720904.USD","GNMX","IBB","SG9999001176.SGD","IBBQ","LU2462157665.USD","IE00BFTCPJ56.SGD","LU0289739699.SGD","LU1559883803.SGD","IE00BJT1NW94.SGD","BK4567","LU1815336091.USD","LU2089984988.USD","LU2468319806.SGD","BK4533","TBXU","BK4532","IE0002270589.USD","LU1069344957.HKD","LU0109394709.USD","LU2237438978.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668180509","title":"Alterity Therapeutics to Spotlight MSA Program at ASX SMIDcaps Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2668180509","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668180509?lang=en_us&edition=fundamental","pubTime":"2026-09-18 07:48","pubTimestamp":1789688927,"startTime":"0","endTime":"0","summary":"Alterity Therapeutics ( ($AU:ATH) ) has shared an update. Alterity Therapeutics, a clinical-stage biotechnology company, develops disease-modifying...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-to-spotlight-msa-program-at-asx-smidcaps-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-to-spotlight-msa-program-at-asx-smidcaps-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","XT","SYNB","JDOC","DARP","IEIH","BBC","BK4139","BBP","BK4007","BK4539","FWD","AGNG","FHLC","LENZ","IBB","BK4588","RSPH","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668990195","title":"Vortex Energy Moves to Acquire Saskatchewan Meadows Project for Future Energy Storage Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2668990195","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668990195?lang=en_us&edition=fundamental","pubTime":"2026-09-18 06:33","pubTimestamp":1789684401,"startTime":"0","endTime":"0","summary":"Vortex Energy Corp. ( ($TSE:VRTX) ) has provided an announcement. Vortex Energy Corp. has entered into an asset purchase agreement to acquire the M...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vortex-energy-moves-to-acquire-saskatchewan-meadows-project-for-future-energy-storage-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vortex-energy-moves-to-acquire-saskatchewan-meadows-project-for-future-energy-storage-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","LU1069344957.HKD","LU2462157665.USD","IDNA","IE00B4R5TH58.HKD","LU2468319806.SGD","LU2324357040.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU1093756325.SGD","LU0417517546.SGD","LU1674673428.USD","LU2417539215.USD","LU0889565916.HKD","GNMX","IE00B894F039.SGD","LU0256863811.USD","LU1430594728.SGD","LU0061475181.USD","BK4532","PBE","LU2456880835.USD","BK4588","BK4567","SG9999001176.SGD","LU2362541513.USD","IBBQ","LU2237438978.USD","IE00BZ9MQY76.HKD","IE00B19Z3B42.SGD","LU0058720904.USD","BIB","SG9999013999.USD","IE00B19Z9Z06.USD","LU0079474960.USD","BK4139","LU2362541273.HKD","LU0109394709.USD","IE0002270589.USD","VRTX","LU1585245621.USD","BBH","LU0432979614.USD","IE00BFTCPJ56.SGD","LU0823416689.USD","SG9999001176.USD","LU2236285917.USD","BK4585","IBB","SGXZ57979304.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668822990","title":"TuHURA Biosciences Expands Use of Revolving Credit Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2668822990","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668822990?lang=en_us&edition=fundamental","pubTime":"2026-09-18 05:32","pubTimestamp":1789680749,"startTime":"0","endTime":"0","summary":"TuHURA Biosciences ( ($HURA) ) just unveiled an update. TuHURA Biosciences, Inc. operates in the biotechnology and life sciences sector and is focu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tuhura-biosciences-expands-use-of-revolving-credit-facility-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tuhura-biosciences-expands-use-of-revolving-credit-facility-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","FHLC","JDOC","SYNB","IEIH","AGNG","FWD","BBP","IBB","BK4588","RSPH","DARP","BK4585","XT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668992198","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2668992198","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668992198?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:34","pubTimestamp":1789677240,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rose 2.17% to $150.89 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 1.14% to 7,637.76 and the Dow Jones Industrial Average  rising 0.61% to 51,778.04.This was the stock's second consecutive day of gains.Gilead Sciences Inc. closed 4.07% below its 52-week high of $157.29, which the company achieved on February 11th.The stock outperformed some of its competitors Thursday, as Johnson & Johnson  rose 1.10% to $270.22, Pfizer Inc.  rose 0.66% to $27.64, and Abbott Laboratories  fell 0.13% to $102.23.Trading volume  eclipsed its 50-day average volume of 6.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 17, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","LU1023059063.AUD","LU1066053197.SGD","SG9999015986.USD","LU0965509010.AUD","LU1571399168.USD","TMED","BK4583","LU0861579265.USD","LU0234570918.USD","BK4532","LU0889565916.HKD","LU1037948541.HKD","LU2087621335.USD","LU2468319806.SGD","LU0320765992.SGD","BK4139","LU0058720904.USD","BK4550","LU1066051498.USD","LU1934455194.USD","MEDI","IE0002270589.USD","LU0882574055.USD","BBH","LU0289739699.SGD","LU2112291526.USD","BK4568","IE00B7SZLL34.SGD","LU1037948897.HKD","LU1585245621.USD","LU0859254822.USD","LU1674673691.USD","LU2324357040.USD","LU1057294990.SGD","LU0965508806.USD","LU0965509283.SGD","IE00BKVL7J92.USD","IE00B19Z3581.USD","LU1778281490.HKD","TBXU","LU2357627491.SGD","IE00B3T34201.USD","BK4566","GILD","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","LU1839511570.USD","BK4578","LU0965509101.SGD","LU0823416689.USD","BK4588","SG9999015952.SGD","LU1430594728.SGD","LU0109394709.USD","IE00BSNM7G36.USD","SG9999015945.SGD","BK4585","LU1061106388.HKD","LU1934455863.HKD","LU1674673428.USD","BMED","LU0114720955.EUR","LU2089984988.USD","SG9999015978.USD","BIB","LU0122379950.USD","IBBQ","LU1934455277.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668992940","title":"Moderna Inc. Stock Climbs 8.5%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2668992940","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668992940?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:33","pubTimestamp":1789677180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 8.5% to $158.07 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.7% to 26,418.30 and the Dow Jones Industrial Average rising 0.6% to 51,778.04.This was the stock's second consecutive day of gains.Moderna Inc. closed 10.5% short of its 52-week high of $176.66, which the company reached on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 1.1% to $270.22, Pfizer Inc. rose 0.7% to $27.64, and Gilead Sciences Inc. rose 2.17% to $150.89.Trading volume totaled 19.1 million, compared to the 50-day average of 17.3 million.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673428.USD","IDNA","MRNY","BK4551","IE00B7SZLL34.SGD","LU0234570918.USD","LU0114720955.EUR","LU1061106388.HKD","TMED","WDNA","LU0882574055.USD","LU0823416689.USD","LU2324357040.USD","MEDI","BBH","IBBQ","BK4534","LU1839511570.USD","MRNA","LU0320765992.SGD","SG9999015986.USD","LU2357627491.SGD","LU0861579265.USD","IE00B19Z3581.USD","IE00BSNM7G36.USD","MRNX","LU0122379950.USD","LU0965509101.SGD","BIB","BMED","LGHT","LU0889565916.HKD","LU0859254822.USD","LU1585245621.USD","LU0289739699.SGD","LU0965509010.AUD","LU1037948897.HKD","BK4501","BK4578","BK4566","GNOM","LU2089984988.USD","IBB","LU1934455863.HKD","BK4568","LU1778281490.HKD","GILD","SG9999015945.SGD","TBXU","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668994030","title":"Ultragenyx confirms FDA approval of Fayuvi","url":"https://stock-news.laohu8.com/highlight/detail?id=2668994030","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668994030?lang=en_us&edition=fundamental","pubTime":"2026-09-18 03:55","pubTimestamp":1789674924,"startTime":"0","endTime":"0","summary":"Ultragenyx (RARE) announced that the U.S. FDA granted standard full approval of Fayuvi, also known as UX111, for the treatment of pediatric patient...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ultragenyx-confirms-fda-approval-of-fayuvi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ultragenyx-confirms-fda-approval-of-fayuvi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","LABU","NVIB","IDNA","BK4139","LFSC","MEDI","MRNY","GNMX","RSPH","IEIH","FRTY","MRNX","GDOC","TBXU","RARE","XLVX","BBP","BK4588","PSCH","PINK","SYNB","IYH","BK4585","BMED","TECB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668994607","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2668994607","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668994607?lang=en_us&edition=fundamental","pubTime":"2026-09-18 03:27","pubTimestamp":1789673226,"startTime":"0","endTime":"0","summary":"Healthcare stocks rose late Thursday afternoon, with the NYSE Healthcare Index adding 0.7% and the State Street Health Care Select Sector SPDR ETF  up 0.6%.The iShares Biotechnology ETF  climbed 2%.In corporate news, Pfizer's  Canadian operation Pfizer Canada ULC and BioNTech  said Thursday that Health Canada has authorized XFG-adapted COMIRNATY COVID-19 vaccine for individuals aged 6 months and older. Pfizer shares added 0.6%, and BioNTech gained 3.2%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999011175.SGD","LU1894683264.USD","LU0868494617.USD","BK4551","LU0985481810.HKD","BNTX","SG9999001176.SGD","LU1023059063.AUD","BK4581","SG9999013999.USD","BK4599","SG9999002224.SGD","LABU","BK4548","BK4592","IE00B19Z3B42.SGD","BK4588","LU0225284248.USD","SGXZ57979304.SGD","SG9999001176.USD","BK4533","LU0170899867.USD","LU0289739699.SGD","SG9999003800.SGD","LU1057294990.SGD","BK4585","IE000M9KFDE8.USD","IE00BLSP4239.USD","LU0321505868.SGD","LU0122379950.USD","XBI","LU0306806265.USD","IE00B3T34201.USD","LU0456855351.SGD","IE00BLSP4452.SGD","IE0002270589.USD","SG9999002232.USD","LU1066051498.USD","LU0234572021.USD","LU2596442595.SGD","LU1066053197.SGD","BK4550","LU0058720904.USD","LU1883839398.USD","BK4534","PFE","LU0306807586.USD","IBB","IE00BBT3K403.USD","OZEM","BK4568","LU0225771236.USD","LU1894683348.USD","XLV","IE00B19Z3581.USD","BK4535","BK4139","LU0321505439.SGD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668991067","title":"FDA approves Ultragenyx gene therapy for Sanfilippo syndrome type A","url":"https://stock-news.laohu8.com/highlight/detail?id=2668991067","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668991067?lang=en_us&edition=fundamental","pubTime":"2026-09-18 02:35","pubTimestamp":1789670130,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration approved Fayuvi, which it calls “the first treatment for pediatric patients with mucopolysaccharidosis type I...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-approves-ultragenyx-gene-therapy-for-sanfilippo-syndrome-type-a-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-approves-ultragenyx-gene-therapy-for-sanfilippo-syndrome-type-a-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","GNOM","CNCR","LABU","FBT","SYNB","BK4588","BK4585","IBB","IBBQ","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668397999","title":"Argenx Expands Kidney Pipeline With New IgA Nephropathy Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2668397999","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668397999?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:30","pubTimestamp":1789662647,"startTime":"0","endTime":"0","summary":"Argenx ($ARGX) announced an update on their ongoing clinical study. Argenx (ARGX) is preparing a Phase 2 study called “A Phase 2, Multicenter, Rand...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/argenx-expands-kidney-pipeline-with-new-iga-nephropathy-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/argenx-expands-kidney-pipeline-with-new-iga-nephropathy-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","IE0002141913.USD","IE00BJT1NW94.SGD","IBB","LU0109394709.USD","FMED","LU0889565916.HKD","LU0320765992.SGD","LU1983260115.SGD","ARGX","TBXU","BK4585","BK4505","IE00B4R5TH58.HKD","LU2324357040.USD","IE00B2B36J28.USD","LU0823416689.USD","BK4139","IE00BFTCPJ56.SGD","IE0034235188.USD","IE00BJJMRZ35.SGD","LU0390134368.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668993629","title":"Amgen Targets First-Line ITP Market With New Phase 3 Romiplostim Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2668993629","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668993629?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:30","pubTimestamp":1789662630,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) is running a Phase 3 study testing romiplostim plus predni...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-targets-first-line-itp-market-with-new-phase-3-romiplostim-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-targets-first-line-itp-market-with-new-phase-3-romiplostim-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","BK4585","LU0289739699.SGD","BK4599","IE0002141913.USD","LU0109394709.USD","PJP","IE00B2B36J28.USD","LU0889565916.HKD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0122379950.USD","BK4534","LU1983299246.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","BBH","BK4588","BK4199","LU2112291526.USD","BK4566","LU1061106388.HKD","LU2242646821.SGD","BK4581","BIB","IE0009355771.USD","LU1057294990.SGD","LU0868494617.USD","PBE","TBXU","IBBQ","SG9999001440.SGD","LU0058720904.USD","LU1571399168.USD","IE00BFTCPJ56.SGD","BK4139","AMGN","BK4533","IBB","ITP","LU2089984988.USD","LU2242652126.USD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668998797","title":"Argenx Se : Jefferies Raises Target Price to $1235 from $1215","url":"https://stock-news.laohu8.com/highlight/detail?id=2668998797","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668998797?lang=en_us&edition=fundamental","pubTime":"2026-09-17 22:13","pubTimestamp":1789654381,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nFWN4590IN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TBXU","IE00BJT1NW94.SGD","IE0034235188.USD","BK4505","LU0390134368.USD","IE0009355771.USD","BK4585","BK4139","IE00BFTCPJ56.SGD","LU0823416689.USD","LU0889565916.HKD","ARGX","LU1983260115.SGD","IE00BJJMRZ35.SGD","IBB","BK4588","LU2324357040.USD","IE0002141913.USD","FMED","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668962770","title":"Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668962770","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668962770?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:40","pubTimestamp":1789648810,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Charles River Labs (CRL) and Amgen (AMGN) with bulli...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-charles-river-labs-crl-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-charles-river-labs-crl-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","LU2242646821.SGD","LU0128526141.USD","LU0390134368.USD","BK4599","LU2468319806.SGD","SG9999001440.SGD","LU2112291526.USD","BIB","BBH","LABU","HCSG","BK4585","PBE","LU1983299246.USD","BK4139","BK4121","PJP","AMGN","CRL","LU0889565916.HKD","LU0757428866.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","IE0009355771.USD","IE00B2B36J28.USD","IE0002141913.USD","TBXU","IBB","IE00B4R5TH58.HKD","LU1815336091.USD","BK4137","IE00BFMHRM44.USD","IBBQ","BK4581","LU1061106388.HKD","XBI","LU0122379950.USD","LU0320765992.SGD","BK4533","BK4534","BK4588","LU0289739699.SGD","LU2089984988.USD","BK4530","IE00BJJMRZ35.SGD","LU0868494617.USD","XLV","LU0029874061.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668996120","title":"Nuvation Bio announces FDA approval of sNDA for Ibtrozi","url":"https://stock-news.laohu8.com/highlight/detail?id=2668996120","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668996120?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:35","pubTimestamp":1789644932,"startTime":"0","endTime":"0","summary":"Nuvation Bio (NUVB) announced that the U.S. FDA has approved a supplemental New Drug Application for Ibtrozi, a ROS1 inhibitor approved for the tre...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvation-bio-announces-fda-approval-of-snda-for-ibtrozi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvation-bio-announces-fda-approval-of-snda-for-ibtrozi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IYH","IEIH","BBP","MRNY","MEDI","TECB","BK4588","MRNX","SYNB","LABU","FRTY","PINK","LFSC","XLVX","IBB","BK4585","NUVB","TBXU","IDNA","PSCH","GDOC","RSPH","NVIB","BK4007","BMED","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668961247","title":"Tiziana Life Sciences Signs Saudi Collaboration MOU for New Multiple Sclerosis Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2668961247","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668961247?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:31","pubTimestamp":1789644661,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences ( ($TLSA) ) has provided an announcement. Tiziana Life Sciences Ltd is a biotechnology company developing immunomodulation th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-signs-saudi-collaboration-mou-for-new-multiple-sclerosis-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-signs-saudi-collaboration-mou-for-new-multiple-sclerosis-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","IBB","LNGR","XT","FHLC","AGNG","IEIH","FWD","JDOC","RSPH","DARP","BBP","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668961345","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Atricure (ATRC) and Stryker (SYK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668961345","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668961345?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:10","pubTimestamp":1789643407,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amgen (AMGN), Atricure (ATRC) and Stryker (SYK) with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-atricure-atrc-and-stryker-syk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-atricure-atrc-and-stryker-syk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2362540622.SGD","HCSG","IBB","LU2506952097.USD","GB00B4LPDJ14.GBP","PBE","BK4082","LU0882574055.USD","LABU","LU0528227936.USD","BK4566","XLV","LU1571399168.USD","XBI","LU2468319806.SGD","SYK","LU2362541513.USD","LU2089984988.USD","LU0690374961.EUR","LU0823417653.USD","LU0868494617.USD","LU0432979614.USD","GB00B4QBRK32.GBP","LU0690374615.EUR","LU0109394709.USD","BK4585","IE0002141913.USD","LU1061106388.HKD","LU2506951875.HKD","LU2324357040.USD","BK4534","LU0058720904.USD","LU0029874061.USD","LU2362541273.HKD","AMGN","BIB","IE00BJT1NW94.SGD","BK4599","BBH","BK4588","IHI","LU2404859667.USD","LU2242652126.USD","ATRC","PJP","BK4581","LU0128526141.USD","TBXU","IBBQ","LU2404859741.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668963550","title":"Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963550","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668963550?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:31","pubTimestamp":1789637460,"startTime":"0","endTime":"0","summary":"KUALA LUMPUR, Malaysia--Malaysian copper-composite manufacturer Vertex Material plans to go public in the U.S. next year after achieving a reported valuation of about $7 billion.The advanced-materials","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2462157665.USD","IDNA","VERX","LU1093756325.SGD","TBXU","LU2362541513.USD","MHGmain","ICOP","LU0432979614.USD","IE0002270589.USD","IE00B2B36J28.USD","COPP","IBB","BK4532","LU2468319806.SGD","UYM","LU0256863811.USD","LU1093756168.USD","LU1035775433.USD","LU2089984988.USD","XME","IE00BFTCPJ56.SGD","LU1069344957.HKD","LU0566484027.USD","IE0009355771.USD","LU0823416689.USD","PBE","BK4023","BBH","GNMX","IE00B894F039.SGD","IE00B19Z9Z06.USD","LU2324357040.USD","LU2236285917.USD","LU0889565916.HKD","COPJ","LU1430594728.SGD","VRTX","CPXR","QCmain","CPER","SG9999013999.USD","LU0320765992.SGD","BK4139","IE00B19Z9P08.USD","IBBQ","BIB","LU2237438978.USD","LU1778281490.HKD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}